Literature DB >> 1981149

Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.

B Bandelow1, P Müller, W Gaebel, W Köpcke, M Linden, F Müller-Spahn, A Pietzcker, F M Reischies, J Tegeler.   

Abstract

A total of 364 schizophrenic outpatients who were stabilized for 3 months on continuous neuroleptic therapy after discharge from the hospital were rated according to three different scales for depressive syndromes (Brief Psychiatric Rating Scale anxious depression factor, AMDP/depression, and the self-rating PD-S depression scale). Between 19.5% and 27.5% of the patients were rated as depressed, or 35.7%-42.8%, when mild depressive syndromes were included. There were low, but significant correlations between demographic or life-event data and depression scores on the self-rating scale, whereas fewer correlations were found on the observer ratings. No associations were found between social adjustment and depression. Moderate correlations were found between measures of the apathetic syndrome and depression ratings, while observer ratings showed higher correlations than the self-rating. High depression scores, especially in the observer ratings, correlated with scales for global psychopathological assessment (CGI, GAS). There were significant correlations between extrapyramidal rigidity and observer rating depression scores, whereas the total amount of neuroleptics given had no influence. These results are interpreted on the basis of hypotheses about depressive syndromes in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981149     DOI: 10.1007/bf02189981

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  53 in total

1.  "Akinetic depression" in schizophrenia.

Authors:  T Van Putten; R P May
Journal:  Arch Gen Psychiatry       Date:  1978-09

2.  The prediction of outcome in schizophrenia. I. Characteristics of outcome.

Authors:  J S Strauss; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1972-12

3.  Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics.

Authors:  F Quitkin; A Rifkin; J Kane; J R Ramos-Lorenzi; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1978-07

4.  Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.

Authors:  S G Siris; F Adan; M Cohen; J Mandeli; A Aronson; E Casey
Journal:  Am J Psychiatry       Date:  1988-12       Impact factor: 18.112

5.  An investigation of the postpsychotic depressive syndrome.

Authors:  T H McGlashan; W T Carpenter
Journal:  Am J Psychiatry       Date:  1976-01       Impact factor: 18.112

6.  Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study.

Authors:  J Galdi; R O Rieder; D Silber; R R Bonato
Journal:  Psychol Med       Date:  1981-11       Impact factor: 7.723

7.  Depression, intellectual impairment, and Parkinson disease.

Authors:  R Mayeux; Y Stern; J Rosen; J Leventhal
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

8.  Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia.

Authors:  R E Becker
Journal:  Am J Psychiatry       Date:  1983-02       Impact factor: 18.112

9.  Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival.

Authors:  M T Tsuang; R F Woolson; J A Fleming
Journal:  Arch Gen Psychiatry       Date:  1980-09

10.  Lithium treatment in post-psychotic depression.

Authors:  D P van Kammen; P E Alexander; W E Bunney
Journal:  Br J Psychiatry       Date:  1980-05       Impact factor: 9.319

View more
  8 in total

Review 1.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

2.  Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?

Authors:  Rozmin Halari; Ravi Mehrotra; Tonmoy Sharma; Veena Kumari
Journal:  Schizophr Bull       Date:  2006-06-07       Impact factor: 9.306

3.  Can patients diagnosed with schizophrenia complete choice-based conjoint analysis tasks?

Authors:  John F P Bridges; Elizabeth T Kinter; Annette Schmeding; Ina Rudolph; Axel Mühlbacher
Journal:  Patient       Date:  2011       Impact factor: 3.883

4.  Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of Germany.

Authors:  B Bandelow; P Müller; U Frick; W Gaebel; M Linden; F Müller-Spahn; A Pietzcker; J Tegeler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 5.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

6.  Schizophrenia - insight, depression: a correlation study.

Authors:  Prasanth Ampalam; Raga Deepthi; Padma Vadaparty
Journal:  Indian J Psychol Med       Date:  2012-01

7.  Depressive symptoms in schizophrenic patients.

Authors:  A Gozdzik-Zelazny; L Borecki; M Pokorski
Journal:  Eur J Med Res       Date:  2011-12-02       Impact factor: 2.175

8.  Psychosocial correlates with depressive symptoms six years after a first episode of psychosis as compared with findings from a general population sample.

Authors:  Yvonne Forsell; Sonja Levander; Johan Cullberg
Journal:  BMC Psychiatry       Date:  2004-10-05       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.